Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Webb

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
JAMA Neurology|November 10, 2015
Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen ActivatorYing Xian, Jerome J Federspiel, Maria Grau-Sepulveda, et al.
Respiratory Medicine|April 19, 2026
Long-term Safety of the Pfizer-BioNTech COVID-19 Vaccine: Results from the HERO-Together StudyEmily C O'Brien, Cherise Wong, Jesse M DeLaRosa, et al.
The Journal of Bone and Joint Surgery. American Volume|November 20, 2019
Effects of Virtual Exercise Rehabilitation In-Home Therapy Compared with Traditional Care After Total Knee Arthroplasty: VERITAS, a Randomized Controlled TrialJanet Prvu Bettger, Cynthia L Green, DaJuanicia N Holmes, et al.
JAMA|March 6, 2023
Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes: A Randomized Clinical TrialNeha J Pagidipati, Adam J Nelson, Lisa A Kaltenbach, et al.
Circulation|July 6, 2021
Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology CommunityAdam J Nelson, Neha J Pagidipati, Vanita R Aroda, et al.
American Heart Journal|December 24, 2024
Discontinuation of SGLT-2i and GLP-1RA among persons with Type 2 diabetes and atherosclerotic cardiovascular disease treated in US cardiology clinicsAdam J Nelson, Lisa A Kaltenbach, Darren K McGuire, et al.
American Journal of Preventive Cardiology|August 14, 2025
Characteristics of patients prescribed SGLT-2i and/or GLP-1RA among cardiology clinics in the US: insights from the COORDINATE-diabetes trialAdam J Nelson, Lisa A Kaltenbach, Hussein R Al-Khalidi, et al.
Circulation|June 27, 2024
Effects of an Intervention to Improve Evidence-Based Care for People With Diabetes and Cardiovascular Disease Across Sex, Race, and Ethnicity Subgroups: Insights From the COORDINATE-Diabetes TrialManasi Tannu, Lisa Kaltenbach, Neha J Pagidipati, et al.
American Heart Journal|October 24, 2022
Coordinating Cardiology clinics randomized trial of interventions to improve outcomes (COORDINATE) - Diabetes: rationale and designAdam J Nelson, Neha J Pagidipati, Michelle D Kelsey, et al.
Contemporary Clinical Trials|August 9, 2021
Design of the Healthcare Worker Exposure Response and Outcomes (HERO) research platformAnne Friedland, Adrian F Hernandez, Kevin J Anstrom, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
JAMA Neurology|November 10, 2015
Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen ActivatorYing Xian, Jerome J Federspiel, Maria Grau-Sepulveda, et al.
Respiratory Medicine|April 19, 2026
Long-term Safety of the Pfizer-BioNTech COVID-19 Vaccine: Results from the HERO-Together StudyEmily C O'Brien, Cherise Wong, Jesse M DeLaRosa, et al.
The Journal of Bone and Joint Surgery. American Volume|November 20, 2019
Effects of Virtual Exercise Rehabilitation In-Home Therapy Compared with Traditional Care After Total Knee Arthroplasty: VERITAS, a Randomized Controlled TrialJanet Prvu Bettger, Cynthia L Green, DaJuanicia N Holmes, et al.
JAMA|March 6, 2023
Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes: A Randomized Clinical TrialNeha J Pagidipati, Adam J Nelson, Lisa A Kaltenbach, et al.
Circulation|July 6, 2021
Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology CommunityAdam J Nelson, Neha J Pagidipati, Vanita R Aroda, et al.
American Heart Journal|December 24, 2024
Discontinuation of SGLT-2i and GLP-1RA among persons with Type 2 diabetes and atherosclerotic cardiovascular disease treated in US cardiology clinicsAdam J Nelson, Lisa A Kaltenbach, Darren K McGuire, et al.
American Journal of Preventive Cardiology|August 14, 2025
Characteristics of patients prescribed SGLT-2i and/or GLP-1RA among cardiology clinics in the US: insights from the COORDINATE-diabetes trialAdam J Nelson, Lisa A Kaltenbach, Hussein R Al-Khalidi, et al.
Circulation|June 27, 2024
Effects of an Intervention to Improve Evidence-Based Care for People With Diabetes and Cardiovascular Disease Across Sex, Race, and Ethnicity Subgroups: Insights From the COORDINATE-Diabetes TrialManasi Tannu, Lisa Kaltenbach, Neha J Pagidipati, et al.
American Heart Journal|October 24, 2022
Coordinating Cardiology clinics randomized trial of interventions to improve outcomes (COORDINATE) - Diabetes: rationale and designAdam J Nelson, Neha J Pagidipati, Michelle D Kelsey, et al.
Contemporary Clinical Trials|August 9, 2021
Design of the Healthcare Worker Exposure Response and Outcomes (HERO) research platformAnne Friedland, Adrian F Hernandez, Kevin J Anstrom, et al.
Pageof 2